US Patent 8476409 Bispecific anti-IGF-1R and anti-ErbB3 antibodies
Patent 8476409 was granted and assigned to Merrimack Pharmaceuticals on July, 2013 by the United States Patent and Trademark Office.
Currently, there are no issues on this topic.
Find more entities like US Patent 8476409 Bispecific anti-IGF-1R and anti-ErbB3 antibodies
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
